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Protein kinases work because their flexibility allows to continuously switch from inactive
to active form. Despite the large number of structures experimentally determined in
such states, the mechanism of their conformational transitions as well as the transition
pathways are not easily to capture. In this regard, computational methods can help to
shed light on such an issue. However, due to the intrinsic sampling limitations, much
efforts have been done to model in a realistic way the conformational changes occurring
in protein kinases. In this review we will address the principal biological achievements
and structural aspects in studying kinases conformational transitions and will focus on the
main challenges related to computational approaches such as molecular modeling and MD
simulations.
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INTRODUCTION
Protein kinases, one of the largest gene families in eukaryotes, are
a class of enzymes which regulates several key cellular processes,
such as cell growth and differentiation.
They all achieve their function by favoring particular structural
arrangements, able to catalyze protein phosphorylation. Despite
the high degree of the conservation of the overall fold, each kinase
is able to respond to specific signals tuning its activity.
Therefore, these molecules represent a unique example of
the nature’s ability to introduce diversification through relatively
small variations to a highly conserved motif.
Such variations, which rarely modify the optimized structure
on the protein free-energy minimum, can severely affect pro-
tein flexibility which in turn might modify the transition patterns
designed to be optimal for their function.
Protein kinases probably represent one of the most remark-
able examples of the importance of the protein flexibility: in fact,
they regulate—continuously switching from active to inactive
state—multiple biological processes by posttranslational phos-
phorylation of serine, threonine and tyrosine residues. In this
context, the knowledge of their structures, although mandatory,
it is not sufficient for a complete understanding of their function,
thus, the description of their conformational transition pathways
is of paramount importance.
However, the experimental techniques able to accurately
describe the transient/intermediate states populated between the
conformational changes are still under development (Ban et al.,
2011; Waldrop, 2014), thus, computational methods can greatly
help in this case.
Atomistic Molecular Dynamics (MD) simulations—based on
the classical mechanics laws and using well-refined empirical
force fields—are probably the most accurate computational tech-
nique for the study of protein flexibility, being able to describe
the dynamical evolution of molecular systems at atomistic level
of detail. Unfortunately, the time-scale reached by standard MD
simulations is still limited by the computational power to the
microsecond, thus excluding processes occurring on longer times,
such as the conformational transitions of almost all kinases.
Therefore, several theoretical-computational techniques able to
enhance the conformational sampling were applied tomodel such
a process.
Here, after presenting the structural features of protein kinases,
we discuss some recent results obtained in modeling kinase con-
formational transitions by enhancing sampling techniques and
brute-force approaches, highlighting their advantages and lim-
its. Finally, due to the involvement of this protein family in very
important diseases such as cancer, we briefly introduce the results
reached in drug design using computational techniques able to
provide a complete description of the accessible conformational
space. We discuss their still full unexploited potential to further
enhance the kinase inhibitor performance.
KINASE STRUCTURE AND CONFORMATIONAL VARIABILITY
To get insights into the structure/dynamics/function relationship
we need to describe their molecular structure in detail. Although
the number of human protein kinase family members is large,
the existing X-ray crystallographic studies showed that the three-
dimensional (3D) structures of their catalytic domains are similar.
Studies based on X-ray structures of PKA revealed that catalytic
subunits of protein kinases share a conserved core consisting of
two lobes. The N-terminal small lobe (N-lobe) and C-terminal
large lobe (C-lobe). These two lobes host a deep pocket that
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accommodates a molecule of ATP bound to one or two diva-
lent cations: magnesium or manganese that compensate for the
strong negative charge of the ATP phosphates (Kornev and Taylor,
2010). This special structural arrangement is required because the
phosphoryl transfer reactions are highly depend on the bond dis-
tances and charge distribution in the reaction transition state.
In particular, structural studies performed with transition state
mimics showed that the presence of Mg2+ ions and positively
charged groups in its vicinity would imply an associative mecha-
nism for phosphoryl transfer, thus optimizing the overall reaction
(Madhusudan et al., 2002). The N-lobe usually includes five
β-strands and an α-helix (hereafter called αC-helix). Despite the
fact that the β-strands form a relatively rigid antiparallel β sheet,
the N-lobe is very dynamic and flexible. The C-lobe is mainly
α-helical (Figure 1) and includes the activation segment, a 20–35
residues stretch located between a conserved DFG motif, and
the APE motif (Huse and Kuriyan, 2002; Nolen et al., 2004),
that is highly conformationally variable and its conformation
can influence both substrate binding and catalytic efficiency. The
C-lobe serves as a docking site for substrate peptides/proteins.
The N-terminal part of the peptide lies in a groove between the
αD and αF-helices on one side and the αG-helix on the other side.
Bioinformatics approaches (Kornev et al., 2006) have shown
that key hydrophobic residues in kinases have a strict organiza-
tion around cores. In particular, the overall fold is joined by two
hydrophobic non-contiguous motifs referred as “spines” (Kornev
et al., 2008). The spines connect all critically important elements
of the protein kinase molecule to a single hydrophobic helix
(αF) that provides their positioning in space. These motifs regu-
late the protein kinase activity. The regulatory spine is typically
assembled after phosphorylation loop and the catalytic one is
FIGURE 1 | Ribbon representation of the molecular fold of the CDK2 in
the closed (cyan) and open conformation (orange). The structures were
extracted from molecular dynamics trajectories (Bešker et al., 2013).
completed by the ATP adenine ring. All these are anchored to the
buried hydrophobic αF helix of the C lobe and provide the basic
architecture of the core.
The “activation loop” is a highly flexible loop, which adopts an
extended conformation in the active kinase domain to function
as a binding platform for the peptide substrate. The experimen-
tal structures of kinases show that αC-helix (in the small lobe)
and the activation loop (in the large lobe) adopt distinct con-
formations associated with the active or different inactive forms.
This extended conformation is stabilized by phosphorylation, as
observed in the active and phosphorylated kinase domain of the
Src-family kinase Lck (Hantschel and Superti-Furga, 2004). In
contrast to the active kinase, the inactive kinases are structurally
diverse (Noble et al., 2004). This diversity arises because no cat-
alytic requirements constrain the fold when it is inactive, with the
presence of different inactive conformations that, nevertheless,
share a number of common structural themes.
In many kinases αC-helix can rotate and change its position,
thereby altering the orientation of key catalytic residues. In the
active state of EGFR kinase, the activation loop maintains a β9
strand and an overall conformation compatible with substrate
binding while the αC-helix is adjacent to the ATP-binding site
(the “αC-in”conformation), and the catalytic important Asp831
residue of the conserved “DFG” motif is found within that site
(“DFG-in”). That is, in the active state, the phenylalanine (Phe)
side-chain occupies the ATP-binding pocket, and the aspartate
(Asp) side-chain is located in the outside of the pocket. When
the so-called “DFG-flip” occurs, the Asp and Phe residues swap:
the Asp side-chain rotates into the ATP-binding pocket, and the
Phe side-chain rotates out of the ATP-binding pocket (DFG-out
conformation), leading the kinases to the inactive state (Shan
et al., 2009). Some human kinases were shown to be able to
adopt the DFG-out conformation (Debondt et al., 1993; Sicheri
et al., 1997; Xu et al., 1997) and it was suggested that the DFG-
in and DFG-out conformations are in dynamic equilibrium and
can interconvert to determine the kinase function (Levinson et al.,
2006).
The protein kinase fold may switch between an active or inac-
tive conformation by extra domains or separate subunits. How
the active and inactive states are stabilized and how states inter-
convert are key questions in understanding kinase regulation.
Typically, the activation segment contains a serine/threonine or
tyrosine residue that can be phosphorylated. This site is referred
to as first “phosphorylation site”; some kinases can have up to
three phosphorylation site in the activation loop and perform
function specific for these kinases. Other kinases, called non-RD
kinases, lack the conserved arginine residue in kinase subdomain
and it has been observed that some of them do not autophospho-
rylate the activation loop and are either constitutively active or
regulated through alternative mechanisms (Dardick and Ronald,
2006). Most protein kinases are comprised of more than just
the kinase domain. This can be flanked by other domains which
tend to be quite dynamic or are part of a multi-subunit com-
plex such as the Cyclin-dependent Kinases (CDK) which require
an activating cyclin or phosphorylase kinase. Others such as the
receptor tyrosine kinases are anchored to membranes and often
have long segments that tether them to the membrane as well
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as long C-terminal tails. Certain protein kinases can be acti-
vated or inhibited by specific polypeptide cofactors. In CDK2 the
activation depends on association with a cyclin subunit via the
interaction of the αC-helix with specific hydrophobic residues on
cyclin that enable the active site to be accessible for phospho-
rylation (Lowe et al., 1997; Lolli, 2010). Many protein kinases
dimerize as part of their activation mechanism, and dimerization
can be regarded as a special case of kinase activation by acces-
sory proteins or domains. In such cases, either both partners are
activated by reciprocal phosphorylation or one partner (the acti-
vator kinase) activates the other (the receiver kinase) through an
allosteric mechanism (Endicott et al., 2012).
COMPUTATIONAL STUDIES: AN OVERVIEW
Computational works focusing on kinase conformational transi-
tions can be divided in two groups: those based on brute-force
approach, where the system was simulated for microseconds and
those where the dynamical evolution of the system was altered
to speed up the sampling. Using the former approach and a
special-purpose supercomputer, the group of D.E. Shaw described
spontaneous transitions in the microsecond time-scale for the
kinase domain of the EFGR from the active to the so-called “Src-
like inactive” conformation by way of two sets of intermediate
conformations, significantly different from the existing crystal
structures. Interestingly, in one of them the helical arrangement
of the activation loop (A-loop) leaves the well-known phospho-
rylation site exposed (Shan et al., 2013). Similarly, Yang et al. used
several independent MD trajectories starting from the putative
intermediate conformations to reconstruct the transitions path-
ways between active and inactive states for the Src kinase and
identified the concerted conformational rearrangements in terms
of structural regions of the protein, such as the A-loop and the
αC-helix (Yang et al., 2009). They also found that transient struc-
tures in not fully active conformations allow exposure of Tyr416
to the bulk solvent—the residue whose phosphorylation locks the
Src in the active state—a feature typical of the fully active states.
In an extensive application of the Replica Exchange MD—an
enhancing sampling technique favoring the overcome of poten-
tial energy barriers—Huang et al. found that the αC-helix acts as
an energy switch between the active and inactive conformations
and describe the sequence of events along the optimal inactiva-
tion path as the fold of the A-loop into the active site followed by
the αC-helix movement (Huang et al., 2012).
Due to the large computational requirements, brute-force
approaches are still limited to few research groups and inevitably
to few systems. Therefore, a class of theoretical-computational
methods able to sample the conformational rearrangements at
limited computational costs were applied to protein kinases.
Perturbative approaches, which are likely to be the most powerful
techniques to model the free energy of a chemical reaction, are
not particularly suited in this case, mainly because it is very diffi-
cult to find a proper reaction coordinate in a high-dimensional
space able to fully discriminate the two conformational states.
Three of such methods, the Targeted, Steered and Biased MD
were applied to model the conformational transitions between
the active/inactive forms of the catalytic domain of LYN kinase,
a member of the Src family of protein tyrosine kinases: the results
showed that although the transition pathways described by these
approaches are similar, the path is strongly dependent on the
choice of progress variable (Huang et al., 2009).
One of the most interesting approaches, however, is based on
the possibility to iteratively select the conformations sampled by
unbiased MD which are most likely to be productive, in order to
limit the time spent in sampling the conformational space regions
within the free-energy minimum basin. In this regard, Beckstein
et al. applied the RMSD as a measure to apply their Dynamic
IMportance Sampling (DIMS) algorithm to describe the zipping
and unzipping of adenylate kinase (Beckstein et al., 2009). From
their results, a cooperative salt bridge zipper is hypothesized to be
the rate-limiting step of the apo-AdK conformational transition.
Following a similar approach, our group applied the Essential
Dynamics algorithm to the description of the conformational
transitions in the CDK2 (Bešker et al., 2013). The power of such a
technique is due to the fact the direction in the high-dimensional
space is described by the native protein movements in its sta-
ble conformational states, e.g., open and closed. In this case, the
choice of the progress variable(s) is natural and self-defined by
the unbiased MD simulations of the starting and target state. In
the case of CDK2, we found that both the opening and closure
follow common transition paths in the essential subspace, involv-
ing the same structural determinants (i.e., the αC-helix and the
activation loop) but in opposite order, indicating that the time-
sequence of such rearrangements determines the specific protein
conformational transition. It is worth noting that due to their
high computational efficiency, the last two methods can be used
to fill the gap between single-system and system-wide studies,
thus providing an unvaluable source of information at the protein
family level.
All the above methods, with their advantages and shortcom-
ings, represent an intriguing field of research and, in the case of
the kinase conformational transitions, they have contributed to a
better description of the transition pathways between the active
and inactive forms.
Nevertheless, several important aspects from a biochemical
point of view are still not well-characterized in detail, including
for example the possibility to bridge the gap between the atomic
description of the transitions and the protein activity and/or the
role played by possible biological partners. In the next few years,
with the support of new or refined enhancing sampling algorithm
and the fast growth of the computational power, we envision
that a better modeling of large conformational rearrangements of
biomolecules, as those occurring in kinases, will be within range
of the scientific community.
INHIBITORS
The central biological role of protein kinases leads to their fre-
quent alteration in several pathologies, first of all cancer. It is
not surprising, therefore, that they are major targets for therapy.
The great number of family members and their high degree of
conservation, however, easily lead to multi target inhibition and
therefore important side effects. First-generation CDK inhibitors,
for instance, targeted the non-specific ATP-binding site and were
discarded in the pre-clinical phase because of their toxic effects
(Lapenna and Giordano, 2009).
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The importance of kinase structural flexibility on the rational
drug design of their inhibitor can be appreciate looking at the
experience of imatinib, the first Bcr-Abl inhibitor approved by the
US Food and Drug Administration that revolutionized treatment
of Chronic Myelogenous Leukaemia (CML). At the time of this
drug discovery, the structural knowledge on the kinase family was
not deep enough to rationalize its mode of action, but several sub-
sequent studies demonstrated that imatinib exploits the change of
conformation of the DFG-motif in the unphosphorylated inactive
form (Lambert et al., 2013). These second generation inhibitors,
targeting a variable region in the inactive form, are more capa-
ble of discerning among kinases but at the same time have the
Achilles’ heel of a greatest rate of drug-resistant mutations (Noble
et al., 2004).
First generation inhibitors, in fact, targeting the active con-
formation, seldom developed drug-resistant mutations because
they would have compromised the kinase activity. The war against
cancer, therefore, moved another step, going against imatinib
resistant cancers.
A growing number of experimentally solved kinase structures
(more than 5000 in PDB database), both in active and inac-
tive forms, and several MD simulations at microsecond-timescale
have changed our knowledge on this protein family. These deep
roots made possible the successful application of in silico ratio-
nal drug design in a growing number of cases: (1) the so-called
hybrid-design was carried out, in which the same kinase inhibitor
targets different protein regions, thus merging the characteristic
of potency (typical of first generation inhibitors) and selectiv-
ity (obtained by second generation ones) (Albaugh et al., 2012);
(2) imatinib was also reengineered to reduce its cardiotoxicity, by
making use of a different water propensity of two residues in the
principal and secondary target kinases (Fernandez et al., 2007).
Several MD simulations were carried out at this scope, that were
able to discriminate the dynamic and structural characteristics of
Bcr-Abl and C-Abl kinases, this last responsible for the cardiotoxic
effects; (3) systematic rigid body docking of potential inhibitors
against 84 unique protein kinases identified three derivatives of
indirubin (Zahler et al., 2007), one of which has been recently
indicated as particularly active against cancer metastasis (Braig
et al., 2013).
The research on better kinase inhibitors by computational
methods has focused not only on the target but on the ligand
as well, with the so-called Pharmacophore Modeling approach,
i.e., “an ensemble of steric and electronic features that is nec-
essary to ensure the optimal supramolecular interactions with a
specific biological target and to trigger (or block) its biological
response” (Wermuth et al., 1998). Modern drug design combines
more computational approach, as in the case of the identifica-
tion of novel inhibitors against thymidine monophosphate kinase
of M. tuberculosis with potent antitubercular activity, obtained
through the combination of pharmacophore modeling, docking
simulation, and structure interaction fingerprint analysis (Kumar
et al., 2009).
It is easy to predict that these coming years will still be rich
of new kinase inhibitors with improved selectivity and mutant
resistance. In fact, new targets, coming from the computational
and experimental characterization of kinase intermediates
are combined with improved computer-aided drug design
methods.
CONCLUSIONS AND PERSPECTIVES
As briefly highlighted in this review, the intrinsic flexibility of
the kinases represents a very intense field of research. The recent
developments in theoretical-computational modeling are con-
tributing to elucidate the actual dynamical behavior of the kinase
domains, thus leading to the possibility of enhancing the design
of new and selective inhibitors using a proper atomistic descrip-
tion of their conformational basins and the pathways along which
they continuously move to tune their activity. Finally, the growth
of computational power as well as the development of new the-
oretical treatments able to model slow and/or rare events at
limited computational costs are making it possible to switch from
single-system modeling of the kinase dynamical behavior to a
system-wide modeling.
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